Southeast Asia Steals Indian Pharma

Red tape, idiosyncratic laws and frustrating regulatory architecture are propelling Indian clinical trials and pharmaceutical companies to relocate to more conducive business environments in Southeast Asia. The beneficiaries, according to the Associated Chambers of Commerce and Industry of India, are Cambodia, the Philippines, Singapore, Thailand, Vietnam and others that are wooing India’s trial research companies and R&D industry with transparent regulations and other benefits.

Read →

Comments on this post are for paid subscribers